Seapolynol and Dieckol Improve Insulin Sensitivity through the Regulation of the PI3K Pathway in C57BL/KsJ-db/db Mice

Hui-Jeon Jeon¹, Kye-Yoon Yoon¹, Eun-Jeong Koh¹, Jia Choi¹, Kui-Jin Kim¹, Hyeon-Son Choi² and Boo-Yong Lee^1,

¹Department of Food Science and Biotechnology, CHA University, Seongnam, South Korea

²Department of Food Science and Technology, Seoul Women’s University, Hwarang, Nowon, Seoul, 139-774, South Korea

Cite this paper:
Hui-Jeon Jeon, Kye-Yoon Yoon, Eun-Jeong Koh, Jia Choi, Kui-Jin Kim, Hyeon-Son Choi and Boo-Yong Lee. Seapolynol and Dieckol Improve Insulin Sensitivity through the Regulation of the PI3K Pathway in C57BL/KsJ-db/db Mice. Journal of Food and Nutrition Research. 2015; 3(10):648-652. doi: 10.12691/jfnr-3-10-5

Abstract

Ecklonia cava, a brown alga native to the seas of Korea and Japan, contains biologically active polyphenols. Seapolynol (SN) is a polyphenol mixture derived from Ecklonia cava, and dieckol (DK) is a major compound of SN. Both Ecklonia cava-derived polyphenols exert an anti-diabetic effect in C57BL/KsJ-db/db mice. SN and DK supplementation significantly reduced bodyweight, water intake, fasting blood glucose, and plasma insulin levels compared with db/db mice. In addition, C-peptide, a biomarker of insulin secretion, was significantly decreased by SN and DK treatment, whereas plasma adiponectin levels, which are associated with insulin sensitivity, was increased by two-fold compared with the db/db group. Regarding plasma lipid profiles, triacylglycerol, total cholesterol, and low-density lipoprotein (LDL) cholesterol, were effectively reduced in the SN- and DK-treated groups. Moreover, the administration of SN and DK activated the insulin signaling pathway, as indicated by the levels of receptor substrate-1 (IRS-1), phosphoinositide 3-kinase (PI3K), serine-threonine specific protein kinase (Akt), and glucose transporter type 4 (GLUT4) in diabetic mice. This result showed that SN and DK regulate blood glucose levels by improving insulin sensitivity in the diabetic condition. Our data suggest that SN and DK may be anti-diabetic agents.

Keywords:
Seapolynol Dieckol Type 2 diabetes C57BL/KsJ-db/db mice IRS-1

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Li Y, Qian ZJ, Ryu B, Lee SH, Kim MM, Kim SK. Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava. Bioorganic & medicinal chemistry 2009; 17:1963-73.
[2]	Kim JH, Lee NS, Jeong YG, Lee JH, Kim EJ, Han SY. Protective efficacy of an Ecklonia cava extract used to treat transient focal ischemia of the rat brain. Anatomy & cell biology 2012; 45:103-13.
[3]	Athukorala Y, Kim KN, Jeon YJ. Antiproliferative and antioxidant properties of an enzymatic hydrolysate from brown alga, Ecklonia cava. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association 2006; 44:1065-74.
[4]	Jung WK, Heo SJ, Jeon YJ, Lee CM, Park YM, Byun HG, et al. Inhibitory effects and molecular mechanism of dieckol isolated from marine brown alga on COX-2 and iNOS in microglial cells. Journal of agricultural and food chemistry 2009; 57:4439-46.
[5]	Lee SH, Min KH, Han JS, Lee DH, Park DB, Jung WK, et al. Effects of brown alga, Ecklonia cava on glucose and lipid metabolism in C57BL/KsJ-db/db mice, a model of type 2 diabetes mellitus. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association 2012; 50:575-82.
[6]	Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414:782-7.
[7]	Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444:840-6.
[8]	Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445:881-5.
[9]	Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. The New England journal of medicine 2001; 344:1343-50.
[10]	Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. Jama 2002; 287:2570-81.
[11]	Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. The Journal of biological chemistry 1957; 226:497-509.
[12]	Knapczyk J. [Kinetics of sodium nitrite decomposition]. Acta poloniae pharmaceutica 1975; 32:683-9.
[13]	Wang C, Mao X, Wang L, Liu M, Wetzel MD, Guan KL, et al. Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1. The Journal of biological chemistry 2007; 282:7991-6.
[14]	Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes care 1998; 21:1288-94.
[15]	Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009; 52:17-30.
[16]	Young PW, Buckle DR, Cantello BC, Chapman H, Clapham JC, Coyle PJ, et al. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma. The Journal of pharmacology and experimental therapeutics 1998; 284:751-9.
[17]	Esposito DL, Li Y, Cama A, Quon MJ. Tyr (612) and Tyr (632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. Endocrinology 2001; 142:2833-40.
[18]	Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. The Journal of clinical investigation 1999; 104:733-41.
[19]	Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414:799-806.